肺结节病
结节病是一种病因不明的肉芽肿性疾病,全球分布,患病率差异大,肺部最常受累,临床病程不可预测。肺结节病 severity 从无症状的影像学异常到难治性慢性进展性疾病不等。过去三十年结节病死亡率似有增加,呼吸衰竭是最常见死因。
要点
- 肺纤维化、高分辨率胸部CT广泛病变、肺功能受损和肺动脉高压是预后不良的明确预测因素。
- 需要全身治疗者,糖皮质激素是最常用的一线治疗,抗代谢药通常作为对激素无反应或不耐受者的替代选择。
- 激素治疗的不良反应与累积剂量和治疗持续时间相关。
核心结论
- 结节病病因不明、病程不可预测,缺乏真正有效的疗法和可靠的个体预后预测因素,使其管理困难。
研究设计与样本
- 综述,检索范围未报告。
主要发现
- 结节病可累及几乎任何器官,但通常以肺部为主。
- 肺结节病 severity 从无症状的偶然影像学异常到对治疗抵抗的慢性进展性疾病。
- 过去三十年结节病死亡率似有增加,呼吸衰竭是最常见的结节病相关死因。
- 肺纤维化、高分辨率胸部CT广泛病变、肺功能受损和肺动脉高压是预后不良的明确预测因素。
临床怎么用
- 需要全身治疗以控制疾病者,糖皮质激素是最常用的一线治疗。
- 对糖皮质激素无反应或不耐受者,抗代谢药通常作为替代选择。
局限性
- 缺乏真正有效的疗法和可靠的个体预后预测因素。
- 糖皮质激素治疗的不良反应与累积剂量和治疗持续时间相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sarcoidosis is a granulomatous disease of unknown cause, occurs worldwide and has a highly variable prevalence. The disease is typically dominant in the lungs, although it can affect virtually any organ and is unpredictable in its clinical course. The severity of pulmonary sarcoidosis ranges from incidentally discovered radiographic abnormalities in asymptomatic patients to a chronic progressive disease that is refractory to treatment. Mortality from sarcoidosis appears to have increased in the past three decades, with respiratory failure being the most common cause of sarcoidosis-related death. Pulmonary fibrosis, extensive disease on high-resolution chest CT, impaired lung function, and pulmonary hypertension are well established predictors of poor clinical outcomes. In patients who need systemic therapy to control their disease, corticosteroids are the most commonly used first-line treatment, with antimetabolites generally representing an alternative for patients who are unresponsive to corticosteroids or who cannot tolerate them. Indeed, corticosteroid therapy is associated with toxic effects that correlate with both the cumulative dose and duration of treatment. The scarcity of truly effective therapies and shortage of reliable predictors of the unpredictable development of disease in individual patients greatly contribute to making sarcoidosis such a difficult disease to manage.
引用
- Spagnolo P, Rossi G, Trisolini R, et al. Pulmonary sarcoidosis. Lancet Respir Med. 2018. PMID: 29625772. doi:10.1016/S2213-2600(18)30064-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。